Munafa Stock Market Course + Intraday & FNO calls 
Akebia Therapeutics (AKBA) Technical (Analysis) Reports Akebia Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Akebia Therapeutics (AKBA)
Technical Analysis Report for USA stock AKBA Akebia Therapeutics. Dated: 05 Oct 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock AKBA Akebia Therapeutics then click here. or read Experts views on Akebia Therapeutics or Forecast & share price targets of Akebia Therapeutics
Akebia Therapeutics Opened at 0.87 and Closed at: 0.92, which is 5.43% of previous session's close. It moved within a range of 0.85 and 0.92
The session was a Bullish session with an average volume of 7150099, which is 0.63% of previous session's volumes.
A Dead cross was found 8 days back on short term averages
Support for tomorrow is 0.89 and resistance for tomorrow is 0.96
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 0.87, 0.83 resistance for tomorrow's hourly charts is 0.94, 0.97
10 Day SMA for Akebia Therapeutics (AKBA) is 0.91 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Akebia Therapeutics (AKBA) is 0.93 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Akebia Therapeutics (AKBA) is 0.98 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 1.05 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Akebia Therapeutics is 1.23 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Akebia Therapeutics is at 0.93 and 200 DMA is at 1.23, while 50 DMA and 100 DMA are at 0.98 and 1.05 respectively
Akebia Therapeutics (AKBA) moving average of 20 SMA is at 0.93 and 20 EMA is at 0.92
| Date | Closing Price | 20 SMA | 20 EMA |
| 05 Mon Oct | 0.92 | 0.93 | 0.92 |
| 02 Fri Oct | 0.87 | 0.93 | 0.92 |
| 01 Thu Oct | 0.87 | 0.93 | 0.93 |
| 30 Wed Sep | 0.92 | 0.94 | 0.94 |
| 29 Tue Sep | 0.89 | 0.94 | 0.94 |
| 28 Mon Sep | 0.89 | 0.94 | 0.94 |
Akebia Therapeutics (AKBA) moving average of 50 SMA is at 0.98 and 50 EMA is at 0.99
| Date | Closing Price | 50 SMA | 50 EMA |
| 05 Mon Oct | 0.92 | 0.98 | 0.99 |
| 02 Fri Oct | 0.87 | 0.98 | 0.99 |
| 01 Thu Oct | 0.87 | 0.99 | 1 |
| 30 Wed Sep | 0.92 | 1 | 1.01 |
| 29 Tue Sep | 0.89 | 1.01 | 1.01 |
| 28 Mon Sep | 0.89 | 1.01 | 1.01 |
Akebia Therapeutics (AKBA) moving average of 100 SMA is at 1.05 and 100 EMA is at 1.12
| Date | Closing Price | 100 SMA | 100 EMA |
| 05 Mon Oct | 0.92 | 1.05 | 1.12 |
| 02 Fri Oct | 0.87 | 1.05 | 1.12 |
| 01 Thu Oct | 0.87 | 1.06 | 1.13 |
| 30 Wed Sep | 0.92 | 1.06 | 1.14 |
| 29 Tue Sep | 0.89 | 1.06 | 1.14 |
| 28 Mon Sep | 0.89 | 1.06 | 1.14 |
Akebia Therapeutics (AKBA) moving average of 200 SMA is at 1.23 and 200 EMA is at 1.37
| Date | Closing Price | 200 SMA | 200 EMA |
| 05 Mon Oct | 0.92 | 1.23 | 1.37 |
| 02 Fri Oct | 0.87 | 1.23 | 1.37 |
| 01 Thu Oct | 0.87 | 1.23 | 1.38 |
| 30 Wed Sep | 0.92 | 1.24 | 1.39 |
| 29 Tue Sep | 0.89 | 1.24 | 1.39 |
| 28 Mon Sep | 0.89 | 1.24 | 1.39 |
Glaxosmithkline Plc has performed better than Akebia Therapeutics in short term. You could have earned much better returns by investing in Glaxosmithkline Plc, about 6.56% more returns!
Akebia Therapeutics has performed better than Glaukos Corporation in short term. Holding Akebia Therapeutics could be a better choice for now!
Zai Lab has performed better than Akebia Therapeutics in short term. You could have earned much better returns by investing in Zai Lab, about 11.51% more returns!
Akebia Therapeutics has performed better than Viking Therapeutics in short term. Holding Akebia Therapeutics could be a better choice for now!
Akebia Therapeutics has performed better than Neuronetics Inc in short term. Holding Akebia Therapeutics could be a better choice for now!
Syndax Pharmaceuticals has performed better than Akebia Therapeutics in short term. You could have earned much better returns by investing in Syndax Pharmaceuticals, about 0.1% more returns!
Akebia Therapeutics has performed better than Prothena Corporation in short term. Holding Akebia Therapeutics could be a better choice for now!
Pacira Pharmaceuticals has performed better than Akebia Therapeutics in short term. You could have earned much better returns by investing in Pacira Pharmaceuticals, about 7.51% more returns!
Orasure Technologies has performed better than Akebia Therapeutics in short term. You could have earned much better returns by investing in Orasure Technologies, about 31.92% more returns!
Akebia Therapeutics has performed better than Nektar Therapeutics in short term. Holding Akebia Therapeutics could be a better choice for now!
Akebia Therapeutics has performed better than Kala Pharmaceuticals in short term. Holding Akebia Therapeutics could be a better choice for now!
Idexx Laboratories has performed better than Akebia Therapeutics in short term. You could have earned much better returns by investing in Idexx Laboratories, about 12% more returns!
Halozyme Therapeutics has performed better than Akebia Therapeutics in short term. You could have earned much better returns by investing in Halozyme Therapeutics, about 10.68% more returns!
Akebia Therapeutics has performed better than Evolus Inc in short term. Holding Akebia Therapeutics could be a better choice for now!
Diamedica Therapeutics has performed better than Akebia Therapeutics in short term. You could have earned much better returns by investing in Diamedica Therapeutics, about 39.43% more returns!
Akebia Therapeutics has performed better than Coherus Biosciences in short term. Holding Akebia Therapeutics could be a better choice for now!
Aptevo Therapeutics has performed better than Akebia Therapeutics in short term. You could have earned much better returns by investing in Aptevo Therapeutics, about 6.42% more returns!
Agios Pharmaceuticals has performed better than Akebia Therapeutics in short term. You could have earned much better returns by investing in Agios Pharmaceuticals, about 3.82% more returns!
Agenus Inc has performed better than Akebia Therapeutics in short term. You could have earned much better returns by investing in Agenus Inc, about 28.31% more returns!
Akebia Therapeutics Technical analysis of indicators
Price action analysis of Akebia Therapeutics (AKBA) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Akebia Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Akebia Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Akebia Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Akebia Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Akebia Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.91 and Akebia Therapeutics AKBA stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Akebia Therapeutics AKBA stock. Volume based technical analysis of Akebia Therapeutics AKBA stock is negative.
Akebia Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock AKBA Akebia Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And AKBA Experts View which covers a lot of information including buying and selling signals
AKBA future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Akebia Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Akebia Therapeutics (AKBA) Technical (Analysis) Reports Akebia Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
